Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zharkinay Absatova"'
Autor:
Zhandos Abay, Sandugash Sadikalieva, Kamshat Shorayeva, Bolat Yespembetov, Makpal Sarmykova, Kuanish Jekebekov, Gaukhar Tokkarina, Zharkinay Absatova, Elina Kalimolda, Yeraly Shayakhmetov, Sabina Moldagulova, Aisha Issabek, Syrym Kopeyev, Alisher Omurtay, Kainar Barakbayev, Markhabat Kassenov, Nazym Syrym, Yergali Abduraimov, Kunsulu Zakarya, Ainur Nurpeisova
Publikováno v:
Journal of Genetic Engineering and Biotechnology, Vol 21, Iss 1, Pp 1-7 (2023)
Abstract Background Bovine Tuberculosis is a respiratory disease caused by the pathogen Mycobacterium bovis (M. bovis) that infects cattle. Though rare, this disease can also affect humans, as well as domestic and wild animals, making it a serious co
Externí odkaz:
https://doaj.org/article/8330f024ea054be384f6168222e9d6be
Autor:
Kamshat Shorayeva, Aziz Nakhanov, Ainur Nurpeisova, Olga Chervyakova, Kuanysh Jekebekov, Zhandos Abay, Nurika Assanzhanova, Sandugash Sadikaliyeva, Elina Kalimolda, Aibol Terebay, Sabina Moldagulova, Zharkinay Absatova, Ali Tulendibayev, Syrym Kopeyev, Gulnur Nakhanova, Aisha Issabek, Sergazy Nurabayev, Aslan Kerimbayev, Lespek Kutumbetov, Yergali Abduraimov, Markhabat Kassenov, Mukhit Orynbayev, Kunsulu Zakarya
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1771 (2023)
Creating an effective and safe vaccine is critical to fighting the coronavirus infection successfully. Several types of COVID-19 vaccines exist, including inactivated, live attenuated, recombinant, synthetic peptide, virus-like particle-based, DNA an
Externí odkaz:
https://doaj.org/article/61ec8e64110c4ec2aa11e3303deeeed9
Autor:
Ainur Nurpeisova, Berik Khairullin, Ruslan Abitaev, Kamshat Shorayeva, Kuanish Jekebekov, Elina Kalimolda, Aslan Kerimbayev, Karligash Akylbayeva, Zhandos Abay, Balzhan Myrzakhmetova, Aziz Nakhanov, Zharkinay Absatova, Sergazy Nurabayev, Mukhit Orynbayev, Nurika Assanzhanova, Khairulla Abeuov, Lespek Kutumbetov, Markhabat Kassenov, Yergaly Abduraimov, Kunsulu Zakarya
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
This article describes the results of a preclinical safety and immunogenicity study of QazCovid-in®, the first COVID-19 vaccine developed in Kazakhstan, on BALB/c mice, rats, ferrets, Syrian hamsters and rhesus macaques (Macaca mulatta). The study
Externí odkaz:
https://doaj.org/article/5ad1a52732d14c0ab5fbc7000b284a8c
Autor:
Zhandos Abay, Ainur Nurpeisova, Kamshat Shorayeva, Sandugash Sadikaliyeva, Bolat Yespembetov, Nazym Syrym, Makhpal Sarmykova, Kuanysh Jekebekov, Ruslan Abitayev, Gaukhar Tokkarina, Elina Kalimolda, Zharkinay Absatova, Sabina Moldagulova, Han Sang Yoo, Markhabat Kassenov, Kunsulu Zakarya, Yergali Abduraimov
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1199 (2023)
This study presents the results of a survey of the safety and protective efficacy of a candidate vector-based vaccine for bovine tuberculosis, using an influenza vector with the NS1 mutation and expressing M. bovis protective antigens ESAT-6 and TB10
Externí odkaz:
https://doaj.org/article/4797a74ec8b14d2f9bb6c08c9ce73007
Autor:
Kuandyk Zhugunissov, Sanat Kilibayev, Muratbay Mambetaliyev, Kunsulu Zakarya, Markhabat Kassenov, Yergaliy Abduraimov, Yerbol Bulatov, Moldir Azanbekova, Zharkinay Absatova, Khairulla Abeuov, Ryspek Nurgaziev, Gourapura J. Renukaradhya, Kairat Tabynov
Publikováno v:
Frontiers in Veterinary Science, Vol 8 (2021)
Camelpox is an infectious viral disease of camels reported in all the camel-breeding areas of Africa, north of the equator, the Middle East and Asia. It causes huge economic loss to the camel industry. We developed a live camelpox virus vaccine candi
Externí odkaz:
https://doaj.org/article/51213e3340dc45caba9425f0e3dbe23d
Autor:
Abduraimov, Zhandos Abay, Ainur Nurpeisova, Kamshat Shorayeva, Sandugash Sadikaliyeva, Bolat Yespembetov, Nazym Syrym, Makhpal Sarmykova, Kuanysh Jekebekov, Ruslan Abitayev, Gaukhar Tokkarina, Elina Kalimolda, Zharkinay Absatova, Sabina Moldagulova, Han Sang Yoo, Markhabat Kassenov, Kunsulu Zakarya, Yergali
Publikováno v:
Vaccines; Volume 11; Issue 7; Pages: 1199
This study presents the results of a survey of the safety and protective efficacy of a candidate vector-based vaccine for bovine tuberculosis, using an influenza vector with the NS1 mutation and expressing M. bovis protective antigens ESAT-6 and TB10